The New Cholinesterase Inhibitors for Alzheimer's Disease, Part 2: Illustrating Their Mechanisms of Action

View This PDF

NB: This article is only available as a PDF.

In last month’s BRAINSTORMS feature, we discussed the distinctive pharmacologic mechanisms of action of 3 new acetylcholinesterase inhibitors, namely donepezil (Aricept), rivastigmine (Exelon), and galantamine (Reminyl).

J Clin Psychiatry 2000;61(11):813-814